TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Micro-X Ltd. ( (AU:MX1) ).
Micro-X Ltd has reached a significant milestone with its Head CT scanner, completing the first imaging test system ready for installation in Australian hospitals. This development marks a crucial step in a pivotal study comparing Head CT images with conventional CT scans for stroke diagnosis, potentially transforming stroke care by enabling rapid point-of-care diagnosis in ambulances. The company has developed advanced technologies, including miniature NEX Technology tubes and novel image reconstruction software, and is collaborating with the Australian Stroke Alliance and other partners. The successful deployment of this technology could revolutionize stroke treatment by allowing prehospital deployment in ambulances, thus moving the hospital to the patient and reducing disability.
The most recent analyst rating on (AU:MX1) stock is a Buy with a A$0.17 price target. To see the full list of analyst forecasts on Micro-X Ltd. stock, see the AU:MX1 Stock Forecast page.
More about Micro-X Ltd.
Micro-X Ltd is an Australian hi-tech company specializing in cold cathode X-ray technology for global health and security markets. The company focuses on developing innovative imaging solutions, including portable CT scanners, with a market emphasis on improving medical diagnostics and emergency response capabilities.
Average Trading Volume: 356,075
Technical Sentiment Signal: Buy
Current Market Cap: A$51.42M
Learn more about MX1 stock on TipRanks’ Stock Analysis page.